2017-Therapy – Disease Modifying

MENACTRIMS ONLINE LIBRARY

The official Online Library of the The Middle East and North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS).

An Update on Pregnancy Outcomes Following Ocrelizumab Treatment in Patients with Multiple Sclerosis and Other Autoimmune Diseases

Sandra Vukusic, Ludwig Kappos, Sibyl Wray, Silvia Bader-Weder, Regine Buffels, Donna Masterman, Julie Napieralski, Stephen L. Hauser

Anti-JCV Antibody Sero-Positivity and Index Value Among Iranian Patients with Multiple Sclerosis and Its Correlation with Demographic Data and Previous Therapies

Sogol Koolaji, Narges Sistany Allahabadi, Arash Ahmadi, Mohammad Ali Sahraian, Sharareh Eskandarieh, Abdolreza Naser Moghadasi, Amir Reza Azimi

Assessment of Clinical Disease Activity and Disability Improvement by Number-Needed-To-Treat Analyses in Patients with Relapsing Multiple Sclerosis Treated with Alemtuzumab Or Ocrelizumab

Raed Alroughani, Giancarlo Comi, Regina Berkovich, Guillermo Izquierdo, Daniel Kantor, Christopher LaGanke, Volker Limmroth, Richard AL Macdonell, Basil Sharrack, Heinz Wiendl

Assessment of Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in a Real Clinical Setting

Raed Alroughani, Samar Ahmed, Raed Behbehani, Jasem Al-Hashel

Bilateral Invasive Breast Carcinoma Complicating Treatment with Natalizumab for Multiple Sclerosis

Mona M. Alkhawajah, Alia M.R. Fallatah

Cladribine Tablets for Treatment of Patients with Multiple Sclerosis (MS): Integrated Analysis of Safety from the MS Clinical Development Program

Stuart Cook, Thomas Leist, Giancarlo Comi, Xavier Montalban, Elke Sylvester, Christine Hicking, Fernando Dangond

Cladribine Tablets in the ORACLE-MS Study Open-Label Maintenance Period: Analysis of Efficacy in Patients After Conversion to Clinically Definite Multiple Sclerosis (CDMS).

Giancarlo Comi, Thomas Leist, Mark S. Freedman, Bruce A. C. Cree, Patricia K. Coyle, Hans-Peter Hartung, Patrick Vermersch, Doris Damian, Fernando Dangond

Cladribine Tablets Produce Selective and Discontinuous Reduction of B and T Lymphocytes and Natural Killer Cells in Patients with Early and Relapsing Multiple Sclerosis (ORACLE-MS, CLARITY and CLARITY Extension)

Olaf Stuve, Per Soelberg-Sorensen, Gavin Giovannoni, Thomas Leist, Yann Hyvert, Doris Damian, Ursula Boschert

Durable Improvements in Clinical Outcomes with Alemtuzumab in Patients with Active Relapsing Remitting Multiple Sclerosis in the Absence of Continuous Treatment: 7-Year Follow-Up of CARE-MS I Patients (TOPAZ Study)

Jihad Said Inshasi, Alexey N Boyko, Jérôme De Seze, Hans-Peter Hartung, Eva Havrdova, Pamela McCombe, Xavier Montalban, Carlo Pozzilli, Patrick Vermersch, David H Margolin

Effectiveness and Safety of Dimethyl Fumurate Treatment in Relapsing Multiple Sclerosis Patients: A Real-World Evidence

Raed Alroughani, Samar Ahmed, Raed Behbehani, Jasem Al-hashel

Efficacy and Safety of Natalizumab Extended Interval Dosing

Maya Zeineddine, Nabil Ayyoubi, Hani Tamim, Johny Nicolas, Samia Khoury, Bassem Yamout

Efficacy of Cladribine Tablets 3.5 Mg/Kg in High Disease Activity (HDA) Subgroups of Patients with Relapsing Multiple Sclerosis (RMS) in the CLARITY Study

Gavin Giovannoni, Kottil Rammohan, Stuart Cook, Giancarlo Comi, Peter Rieckmann, Per Soelberg-Sorensen, Patrick Vermersch, Fernando Dangond, Christine Hicking

Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) in the 120-Week Extension to the CLARITY Study

Gavin Giovannoni, Giancarlo Comi, Stuart Cook, Peter Rieckmann, Kottil Rammohan, Per Soelberg-Soerensen, Patrick Vermersch, Emily Martin, Fernando Dangond

Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Primary Progressive Multiple Sclerosis in the ORATORIO Trial

Xavier Montalban, Jerry Wolinsky, Ludwig Kappos, Stephen L. Hauser, Gavin Giovannoni, Jerome de Seze, Amit Bar-Or, Donna Masterman, Corrado Bernasconi, Wei Wei, Hideki Garren, P Chin, S Belachew, DL Arnold

Highlights On Cyclophosphamide Effect in Active Relapsing Remitting Multiple Sclerosis

Magd Fouad Zakaria, Mahmoud Saad Swelam, Dina AbdEl-Gawad Zamzam, Ayman Mohamed Nasef, Samia Ashor Helal, Mohamed Aly Abdel Hafeez, Alaa Mohamed Abou Steit, Shaimaa Sayed Khater, Mohamad Mahmoud Fouad, Ayman Abdel Hady, Mohamed Hamdi Attia

Long Term Effect of Delaying Disease Modifying Therapy in Patients with Multiple Sclerosis Due to Pregnancy Planning

Seraj Makkawi, Dina Lavorato, Jamie Greenfield, Helene Parpal, Luanne Metz

Long-Term Lymphocyte Counts in Patients with RRMS Treated with Cladribine Tablets

Per Soelberg-Sorensen, Fernando Dangond, Christine Hicking, Gavin Giovannoni

Outcomes of Iraqi Multiple Sclerosis Patients that Treated with Natalizumab

Akram M. Al-Mahdawi, Anmar Oday Hatem, Omar Tahseen Mohammed

Preliminary Results of the OPERA I and OPERA II Open-Label Extension Study

Robert T. Naismith, Mark Cascione, Luigi Maria Edoardo Grimaldi, Stephen L. Hauser, Ludwig Kappos, Xavier Montalban, Jerry Wolinsky, Peter Chin, Hideki Garren, Laura Julian, Fabian Model, D Honeycutt

Rapid Onset of Ocrelizumab Suppression of Brain MRI Activity in Relapsing-Remitting Multiple Sclerosis

Frederik Barkhof, Ludwig Kappos, Amit Bar-Or, David Li, Shibeshih Belachew, Laura Julian, Annette Sauter, Daniela Stokmaier, Stephen L. Hauser

Rapidity of Onset of Ocrelizumab Clinical Efficacy in Relapsing Multiple Sclerosis

Stephen L. Hauser, Ludwig Kappos, Amit Bar-Or, Hans-Peter Hartung, Shibeshih Belachew, Jian Han, Laura Julian, Julie Napieralski, Jerry Wolinsky

Rebound Syndrome After Teriflunomide Cessation in a Patient with Multiple Sclerosis

Bassem Yamout, Marianne Said, Salem Hannoun, Maya Zeineddine, Joelle Massouh, Samia Khoury

Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study

Maya Zeineddine, Nabil Ayyoubi, Johny Nicolas, Samia Khoury, Bassem Yamout

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis

Stephen L. Hauser, Ludwig Kappos, Xavier Montalban, Carol-Jean Guittari, Harold Koendgen, Carrie Li, Carole Marcillat, David Wormser, Jerry Wolinsky

The Use of Natalizumab in Pediatric Patients with Active Relapsing Multiple Sclerosis: A Prospective Study